GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mallinckrodt PLC (OTCPK:MCKPF) » Definitions » Cyclically Adjusted PB Ratio

Mallinckrodt (Mallinckrodt) Cyclically Adjusted PB Ratio : 0.00 (As of Jun. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Mallinckrodt Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Mallinckrodt's current share price is $0.12. Mallinckrodt's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $51.46. Mallinckrodt's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Mallinckrodt's Cyclically Adjusted PB Ratio or its related term are showing as below:

During the past years, Mallinckrodt's highest Cyclically Adjusted PB Ratio was 0.65. The lowest was 0.01. And the median was 0.17.

MCKPF's Cyclically Adjusted PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.875
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Mallinckrodt's adjusted book value per share data for the three months ended in Mar. 2024 was $55.437. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $51.46 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mallinckrodt Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Mallinckrodt's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mallinckrodt Cyclically Adjusted PB Ratio Chart

Mallinckrodt Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.16

Mallinckrodt Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.14 0.02 - -

Competitive Comparison of Mallinckrodt's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mallinckrodt's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mallinckrodt's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mallinckrodt's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mallinckrodt's Cyclically Adjusted PB Ratio falls into.



Mallinckrodt Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Mallinckrodt's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.12/51.46
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mallinckrodt's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Mallinckrodt's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=55.437/120.9901*120.9901
=55.437

Current CPI (Mar. 2024) = 120.9901.

Mallinckrodt Quarterly Data

Book Value per Share CPI Adj_Book
201403 22.901 100.573 27.550
201406 22.684 100.773 27.235
201409 42.767 100.474 51.500
201412 43.639 99.576 53.023
201503 44.378 99.975 53.706
201506 45.177 100.573 54.348
201509 45.675 100.274 55.111
201512 46.134 99.676 55.999
201603 46.643 99.676 56.617
201606 48.381 101.072 57.916
201609 49.182 100.274 59.343
201612 47.620 99.676 57.803
201703 51.449 100.374 62.016
201706 52.461 100.673 63.048
201709 53.448 100.474 64.362
201712 75.542 100.075 91.330
201803 77.165 100.573 92.830
201806 77.913 101.072 93.268
201809 79.328 101.371 94.681
201812 34.652 100.773 41.604
201903 36.558 101.670 43.505
201906 36.645 102.168 43.396
201909 36.637 102.268 43.344
201912 23.075 102.068 27.353
202003 22.513 102.367 26.609
202006 11.465 101.769 13.630
202009 13.779 101.072 16.494
202012 12.047 101.072 14.421
202103 10.386 102.367 12.275
202106 9.160 103.364 10.722
202109 6.060 104.859 6.992
202112 3.699 106.653 4.196
202203 2.301 109.245 2.548
202206 162.343 112.779 174.162
202209 140.393 113.504 149.653
202212 122.520 115.436 128.415
202303 103.592 117.609 106.570
202306 47.061 119.662 47.583
202309 -82.210 120.749 -82.374
202403 55.437 120.990 55.437

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mallinckrodt  (OTCPK:MCKPF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Mallinckrodt Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Mallinckrodt's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mallinckrodt (Mallinckrodt) Business Description

Traded in Other Exchanges
N/A
Address
College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, IRL, 15
Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which include specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of its revenue from the United States.
Executives
Alta Fundamental Advisers Llc 10 percent owner 1500 BROADWAY, SUITE 704, NEW YORK NY 10036
Jason Daniel Goodson officer: EVP & Head of Corp Development 106 CENTRAL PARK AVENUE, WENTZVILLE MO 63885
James R Sulat director
Paul Bisaro director
Sigurdur O Olafsson director, officer: President and CEO 360 MOUNT KEMBLE AVENUE, MORRISTOWN NJ 07960
Stephen Andrew Welch officer: EVP & Head of Spec Generics 18440 BRIDGEMORE LANE, LOUISVILLE KY 40245
Peter C Richardson officer: EVP & Chief Scientific Officer 28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Susan Michele Silbermann director C/O LIANBIO, 103 CARNEGIE CENTER DRIVE, SUITE 215, PRINCETON NJ 08540
Lisa French officer: EVP & Chief Commercial Officer 301 CONTINENTAL LANE, PAOLI PA 19301
Mark Anthony Tyndall officer: EVP & Chief Legal Offi & Secre 1101 Q ST NW, WASHINGTON DC 20009
Henriette Nielsen officer: EVP & Chief Transformation OFC 202 WEST 85TH STREET, APT. 5, NEW YORK NY 10024
Karen Ling director C/O FOREST LABORATORIES, INC., 909 THIRD AVENUE, NEW YORK NY 10022
Anne Clem Whitaker director 109 BRIERY BRANCH COURT, MORRISVILLE NC 27560
Olifant Luxco S.a R.l. 10 percent owner 19, RUE DE BITBOURG, LUXEMBOURG N4 L-1273
Paul Rutherford Carter director SOUTH BUILDING, 2 ROUNDWOOD AVENUE, STOCKLEY PARK X0 UB11 1AF

Mallinckrodt (Mallinckrodt) Headlines

From GuruFocus